Zobrazeno 101 - 110
of 410
pro vyhledávání: '"Bernard A. Fox"'
Autor:
Jana Beer, Claudia Wickenhauser, Bernard A. Fox, Alexander W. Eckert, Juergen Bukur, Matthias Kappler, Daniel Bethmann, André Steven, Barbara Seliger
Publikováno v:
Cancers
Volume 13
Issue 4
Cancers, Vol 13, Iss 620, p 620 (2021)
Volume 13
Issue 4
Cancers, Vol 13, Iss 620, p 620 (2021)
Simple Summary Oral squamous cell carcinoma has developed different strategies to escape from T-cell-mediated immune surveillance, which is mediated by changes in the composition of cellular and soluble components of the tumor microenvironment as wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cdcb61e895e41de3a6efe06fe7da45a
https://publica.fraunhofer.de/handle/publica/266266
https://publica.fraunhofer.de/handle/publica/266266
Autor:
Giampaolo Tortora, Bernard A. Fox, Ramy Ibrahim, Christian U. Blank, Alexander M.M. Eggermont, Michael Lahn, Anna Maria Di Giacomo, Michele Maio, R. Bryan Bell, Andrea Necchi
The Italian Network for Tumor Biotherapy (Network Italiano per la Bioterapia dei Tumori [NIBIT]) Foundation hosted its annual 2020 Think Tank meeting virtually, at which representatives from academic, clinical, industry, philanthropic, and regulatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba278732050d946d514842ba857bcca
https://hdl.handle.net/11365/1233299
https://hdl.handle.net/11365/1233299
Autor:
Kimberly Samson, Eric Tran, David Ross, Bernard A. Fox, Thomas Duhen, Pippa Newell, Brady Bernard, Carmen Ballesteros-Merino, Venkatesh Rajamanickam
Publikováno v:
Cancer immunology research. 9(6)
Microsatellite-stable (MSS) colorectal cancers are characterized by low mutation burden and limited immune-cell infiltration and thereby respond poorly to immunotherapy. Here, we report a case of metastatic MSS colorectal cancer with a robust antican
Autor:
James Cardia, Jacob Moses, Nicholas P. Morris, Tarsem Moudgil, Bernard A. Fox, Richard Bryan Bell, Melissa Maxwell, Joshua Rios, Dingxue Yan, Simon Fricker, Ryan Montler, Colin Thalhofer, Andrew D. Weinberg
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Tumor Infiltrating Lymphocyte (TIL) therapy has proven effective for patients with stage IV melanoma, however there are critical issues that can limit the efficacy of standard TIL therapy across a wide range of different malignancies. We a
Autor:
Christopher Stuart Baker, Jack Lee, Tom Van Hagen, Victoria Atkinson, Bernard A. Fox, Carmen Ballesteros-Merino, Eric D. Whitman, Kellie Malloy Foerter, Reneta Hermiz, Sajeve Thomas, Scott J. Diede, Elizabeth Buchbinder, Katy K. Tsai, Catalin Mihalcioiu, Shawn M. Jensen, Rachel Roberts-Thomson, Sandra Aung, David A. Canton, Alain Algazi, Christopher G. Twitty, Mecker G. Möller, Clemens Krepler, Donna Bannavong, Emmett V. Schmidt, Marcus O. Butler, John R. Hyngstrom, Erica Browning, Jon Salazar, M. Shaheen, Adil Daud, Matteo S. Carlino, Andrew Mant, C. Lance Cowey, Gregory A. Daniels, Lauren Svenson, Pablo Fernandez-Penas, Igor Puzanov, Jendy Sell, Andrew Haydon
Publikováno v:
Late-breaking abstracts.
Background Electroporated plasmid IL-12 (TAVO or tavokinogene telseplasmid) is a novel pro-inflammatory intratumoral therapy with substantial single agent activity in melanoma, which has been shown to synergize with anti-PD-1 antibodies in patients p
Autor:
Walter J. Urba, Hong-Ming Hu, Michael E. Afentoulis, Brian D. Piening, Bernard A. Fox, Daniel S. O'Connor, Glenna McDonnell, Jack Lee, Mia Han, Rom Leidner, Keith W. Wegmann, Kim Jaffe, Traci L Hilton, Biance Nguyen, John F. Rodriguez, Christopher Paustian, Madelein Laws, Carlo Bifulco, Shawn M. Jensen, David A. Canton, Tarsem Moudgil, Kellie Malloy Foerter, Christopher G. Twitty
Publikováno v:
Regular and young investigator award abstracts.
Background SARS-CoV-2 (CoV2) has precipitated a global pandemic and the effectiveness of standard vaccine strategies to induce potent and persistent immunity to CoV2 is in question, particularly for the elderly. This problem is not dissimilar to what
Autor:
Jana Beer, Matthias Kappler, Juergen Bukur, Bernard A. Fox, Daniel Bethmann, Barbara Seliger, André Steven, Alexander W. Eckert, Claudia Wickenhauser
Progression of oral squamous cell carcinoma (OSCC) has been associated with an escape of tumor cells from the host immune surveillance with growing evidence of its underlying molecular mechanisms and its interaction with the immune cell control. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16610566e6bee7130f1b3527c5e4d3b6
https://doi.org/10.20944/preprints202009.0238.v1
https://doi.org/10.20944/preprints202009.0238.v1
Autor:
Charles G. Drake, Walter J. Urba, David Kaufman, Leisha A. Emens, Jeffrey S. Weber, Alessandra Cesano, Douglas G. McNeel, Ana C. Anderson, Marcela V. Maus, Mario Sznol, Jon M Wiggington, Lisa H. Butterfield, Patrick Hwu, David Parkinson, Ernest C. Borden, James L. Gulley, Michael J. Mastrangelo, Michael B. Atkins, Kim Margolin, Julie R. Brahmer, Thomas F. Gajewski, Robert O. Dillman, Pedro Romero, Daniel S. Chen, Francesco M. Marincola, George J. Weiner, Paolo A. Ascierto, Tanja D. de Gruijl, Michael T. Lotze, Paul M. Sondel, F. Stephen Hodi, Bernard A. Fox, Stefani Spranger, Howard L. Kaufman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for immunotherapy of cancer, vol. 8, no. 1
Ascierto, P A, Fox, B, Urba, W, Anderson, A C, Atkins, M B, Borden, E C, Brahmer, J, Butterfield, L H, Cesano, A, Chen, D, De Gruijl, T, Dillman, R O, Drake, C G, Emens, L A, Gajewski, T F, Gulley, J L, Stephen Hodi, F, Hwu, P, Kaufman, D, Kaufman, H, Lotze, M, McNeel, D G, Margolin, K, Marincola, F, Mastrangelo, M J, Maus, M V, Parkinson, D R, Romero, P J, Sondel, P M, Spranger, S, Sznol, M, Weiner, G J, Wiggington, J M & Weber, J S 2020, ' Insights from immuno-oncology : The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19 ', Journal for Immunotherapy of Cancer, vol. 8, no. 1, e000878 . https://doi.org/10.1136/jitc-2020-000878
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer
Journal for immunotherapy of cancer, vol. 8, no. 1
Ascierto, P A, Fox, B, Urba, W, Anderson, A C, Atkins, M B, Borden, E C, Brahmer, J, Butterfield, L H, Cesano, A, Chen, D, De Gruijl, T, Dillman, R O, Drake, C G, Emens, L A, Gajewski, T F, Gulley, J L, Stephen Hodi, F, Hwu, P, Kaufman, D, Kaufman, H, Lotze, M, McNeel, D G, Margolin, K, Marincola, F, Mastrangelo, M J, Maus, M V, Parkinson, D R, Romero, P J, Sondel, P M, Spranger, S, Sznol, M, Weiner, G J, Wiggington, J M & Weber, J S 2020, ' Insights from immuno-oncology : The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19 ', Journal for Immunotherapy of Cancer, vol. 8, no. 1, e000878 . https://doi.org/10.1136/jitc-2020-000878
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer
The hypoxia and profound inflammatory response associated with the pneumonitis observed with the severe acute respiratory virus coronavirus-2 (SARS-COV-2) virus responsible for the recent COVID-19 pandemic has overwhelmed intensive care facilities in
Autor:
Matthias Kappler, Carlo Bifulco, Claudia Wickenhauser, Lauren Hum, Carmen Ballesteros-Merino, Daniel Bethmann, Barbara Seliger, Claudia Keschke, Shu-Ching Chang, Richard Bryan Bell, Zipei Feng, Alexander W. Eckert, Bernard A. Fox
Publikováno v:
HeadneckREFERENCES. 43(2)
Background This study aimed to analyze margin status and the impact of the immune elements on recurrence in patients with oral squamous cell carcinoma (OSCC), employing a prognostic biomarker, cumulative suppressive index (CSI), which reflects FoxP3+
Autor:
Fabienne Hermitte, Bernhard Mlecnik, Alessandro Lugli, Carlo Bifulco, Franck Pages, Eva Zavadova, Francesco M. Marincola, Pamela S. Ohashi, M. Van den Eynde, F. Marliot, P.A. Ascierto, Jérôme Galon, Bernard A. Fox, A. Hartmann, Yutaka Kawakami, Youhan Wang, Toshihiko Torigoe, Michael H.A. Roehrl, Iris D. Nagtegaal, P. Patel
Publikováno v:
Annals of Oncology, Vol. 31, no.3, p. 238 (2020)
Background The present study was performed to evaluate the predictive capacity of the TNM-Immune (TNM-I) classification staging system vs. the 8th edition of the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1640e04530d526d73a6d7d0d98f518d
https://hdl.handle.net/2078.1/273098
https://hdl.handle.net/2078.1/273098